Balaji Steroids And Hormones Profile
Key Indicators
- Authorised Capital ₹ 4.95 Cr
as on 15-12-2024
- Paid Up Capital ₹ 4.95 Cr
as on 15-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 15.85 Cr
as on 15-12-2024
- Satisfied Charges ₹ 6.78 Cr
as on 15-12-2024
- Revenue -96.20%
(FY 2021)
- Profit 7.25%
(FY 2021)
- Ebitda 70.66%
(FY 2021)
- Net Worth -762.98%
(FY 2021)
- Total Assets -7.38%
(FY 2021)
About Balaji Steroids And Hormones
The Corporate was formerly known as Maikal Kanya Drugs Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.95 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹15.85 Cr. The company has closed loans amounting to ₹6.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jasmina Aildasani, Akshay Aildasani, and Sidharth Aildasani serve as directors at the Company.
- CIN/LLPIN
U24230MP2010PTC023386
- Company No.
023386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dhar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Balaji Steroids And Hormones?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sidharth Aildasani  | Director | 12-Jan-2016 | Current |
| Jasmina Aildasani | Director | 23-Mar-2019 | Current |
| Akshay Aildasani | Director | 19-Oct-2015 | Current |
Financial Performance of Balaji Steroids And Hormones.
Balaji Steroids And Hormones Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 96.2% decrease. The company also saw a slight improvement in profitability, with a 7.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 762.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Balaji Steroids And Hormones?
In 2021, Balaji Steroids And Hormones had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Broadway Pharmaceuticals Private LimitedActive 2 years 3 months
Jasmina Aildasani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Jun 2019 | ₹2.50 Cr | Open |
Others Creation Date: 26 Jul 2017 | ₹13.35 Cr | Open |
The Cosmos Cooperative Bank Ltd. Creation Date: 27 Sep 2014 | ₹1.78 Cr | Satisfied |
How Many Employees Work at Balaji Steroids And Hormones?
Unlock and access historical data on people associated with Balaji Steroids And Hormones, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balaji Steroids And Hormones, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaji Steroids And Hormones's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
